Documentation
Vendor-supplied data
COA stated as available
Not independently documented
Checked
Jul 18, 2026
Growth Hormone Secretagogue
Also known as: Somatropin Β· Human growth hormone Β· Genotropin Β· Norditropin Β· GH
Recombinant growth hormone, approved for genuine GH deficiency and specific growth disorders. Anti-ageing and body-composition use in healthy adults is not supported and is legally restricted in the US.
Crystal Peptides. The table lists only product-specific offers that were checked and for which a real destination exists. Missing prices, quantities, stock and laboratory details are not inferred.
Somatropin is recombinant human growth hormone (HGH), a 191-amino-acid protein identical to the growth hormone made by the pituitary gland. It is an approved prescription drug used to replace deficient growth hormone or treat certain growth disorders under medical supervision.
Strong clinical evidence and regulatory approval support its use in genuine growth-hormone deficiency and defined paediatric growth disorders. For anti-ageing or body-composition use in healthy adults, a systematic review (Annals of Internal Medicine, 2007) found only small body-composition changes offset by higher rates of adverse events, and concluded it cannot be recommended as an anti-ageing therapy.
A prescription hormone with significant risks, including fluid retention, joint and muscle pain, carpal tunnel syndrome, and insulin resistance or impaired glucose tolerance. It is contraindicated in acute critical illness and active malignancy, with an increased-mortality signal in critically ill patients. Non-medical use is unsafe and, in the US, unlawful.
An approved prescription medicine (somatropin) in the EU and US for defined growth-hormone-deficiency and growth disorders in children and adults. In the US, distributing HGH for non-approved uses such as anti-ageing or athletic enhancement is specifically prohibited by federal law (21 U.S.C. Β§333(e)). Prescription-only.
Vendor comparison
The table lists only product-specific offers that were checked and for which a real destination exists. Missing prices, quantities, stock and laboratory details are not inferred.
Documentation
Vendor-supplied data
COA stated as available
Not independently documented
Checked
Jul 18, 2026
Affiliate disclosure: This page contains affiliate links. peptides.cx may receive a commission when a purchase is made through one of these links. Evidence ratings, safety summaries and editorial content are produced independently from vendor relationships.
Somatropin is recombinant human growth hormone (HGH), a 191-amino-acid protein identical to the growth hormone made by the pituitary gland. It is an approved prescription drug used to replace deficient growth hormone or treat certain growth disorders under medical supervision.
Somatropin is recombinant human growth hormone (HGH), a 191-amino-acid protein identical to the growth hormone made naturally by the pituitary gland. As an approved prescription drug β sold under brand names such as Genotropin and Norditropin β it is used to replace deficient growth hormone or to treat certain defined growth disorders under medical supervision. It is a prescription-only medicine, and that status is central to understanding both its legitimate use and the controversy around its misuse.
The clinical evidence is strong where the indication is genuine. Regulatory approval and robust trials support somatropin for true growth-hormone deficiency and for specific paediatric growth disorders in both children and adults. The picture is very different for the anti-ageing and body-composition uses that dominate online discussion: a systematic review in healthy older adults (Annals of Internal Medicine, 2007) found only small changes in body composition, offset by higher rates of adverse events, and concluded that growth hormone cannot be recommended as an anti-ageing therapy. Its mechanism β growth-hormone-receptor agonism that drives IGF-1 production, lipolysis, and protein anabolism β is well characterized, but a real biological effect is not the same as a safe or beneficial one in healthy people.
HGH is a prescription hormone with significant risks, including fluid retention, joint and muscle pain, carpal tunnel syndrome, and insulin resistance or impaired glucose tolerance. It is contraindicated in acute critical illness and active malignancy, and an increased-mortality signal has been reported in critically ill patients. Non-medical use is unsafe, and in the United States it is also unlawful: federal law (21 U.S.C. Β§333(e)) specifically prohibits distributing HGH for non-approved uses such as anti-ageing or athletic enhancement. This page is an educational reference summarizing what the evidence and the law establish; it is not medical advice, and it does not provide dosing, protocols, or sourcing guidance.
Evidence grade: A
Strong clinical evidence and regulatory approval support its use in genuine growth-hormone deficiency and defined paediatric growth disorders. For anti-ageing or body-composition use in healthy adults, a systematic review (Annals of Internal Medicine, 2007) found only small body-composition changes offset by higher rates of adverse events, and concluded it cannot be recommended as an anti-ageing therapy. Growth, metabolic, and IGF-1-axis effects are extensively characterised across species.
Strong clinical evidence and regulatory approval support its use in genuine growth-hormone deficiency and defined paediatric growth disorders. For anti-ageing or body-composition use in healthy adults, a systematic review (Annals of Internal Medicine, 2007) found only small body-composition changes offset by higher rates of adverse events, and concluded it cannot be recommended as an anti-ageing therapy.
Growth, metabolic, and IGF-1-axis effects are extensively characterised across species.
A prescription hormone with significant risks, including fluid retention, joint and muscle pain, carpal tunnel syndrome, and insulin resistance or impaired glucose tolerance. It is contraindicated in acute critical illness and active malignancy, with an increased-mortality signal in critically ill patients. Non-medical use is unsafe and, in the US, unlawful.
An approved prescription medicine (somatropin) in the EU and US for defined growth-hormone-deficiency and growth disorders in children and adults. In the US, distributing HGH for non-approved uses such as anti-ageing or athletic enhancement is specifically prohibited by federal law (21 U.S.C. Β§333(e)). Prescription-only.